22:39 , Mar 29, 2019 |  BioCentury  |  Finance

ORI goes oncolytic

Oncolytic virus company Cold Genesys continues to draw East Asian investors on the back of its data in bladder cancer. ORI Healthcare Fund L.P.'s Simone Song said the Hong Kong fund had been following Cold...